Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach [NA]
Clinical trial update from University of Missouri-Columbia describing an individualized approach to assessing metabolic outcomes after weigh…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Biomarkers of Steatohepatitis in Type 2 Diabetes Patients
This clinical trial update describes a study on biomarkers of steatohepatitis in patients with type 2 diabetes, which is currently not yet r…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis [NA]
This clinical trial update describes NCT02933554, evaluating bariatric embolization of arteries as a treatment for nonalcoholic steatohepati…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
A prospective cohort and biobank study on nonalcoholic fatty liver disease and related steatohepatitis (NAFLD/MASH/NASH) is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients [NA]
A recruiting trial evaluating the accuracy of imaging techniques for diagnosing non-alcoholic steatohepatitis and fibrosis in patients with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis [NA]
A clinical trial update indicates recruitment for a study evaluating vertical sleeve gastrectomy plus lifestyle modification for Nonalcoholi…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) [Phase 3]
This is a Phase 3 clinical trial update indicating the MAESTRO-NASH-OUTCOMES study of resmetirom in patients with well-compensated NASH cirr…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: The COherence of Scatter Identification and Exclusion Algorithm Study
A clinical trial update for the COherence of Scatter Identification and Exclusion Algorithm Study, sponsored by the Institute of Cancer Rese…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects [Phase 1]
Phase 1 clinical trial update evaluating safety, tolerability, pharmacokinetics, and food effects of IMM-H014 in healthy subjects, with a fo…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) [Phase 2]
A Phase 2 clinical trial update for efruxifermin in adults with nonalcoholic steatohepatitis and compensated cirrhosis shows the study is ac…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
A clinical trial update on a cell-based therapy using C-Kit positive hepatic endothelial cells with MerTK deficiency for nonalcoholic fatty …
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Low-Dose Pioglitazone in Patients With NASH (AIM 2) [Phase 2]
This clinical trial update reports a Phase 2 study of low-dose pioglitazone for nonalcoholic steatohepatitis in patients with type 2 diabete…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Longitudinal Observational Study Of Chinese With NAFLD/NASH
A longitudinal observational study enrolling Chinese participants with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis is c…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Nonalcoholic Steatohepatitis in Chinese Children
A clinical trial registry entry updates the status to recruiting for a study on non-alcoholic fatty liver disease and nonalcoholic steatohep…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD [Phase 4]
Phase 4 clinical trial investigating the effect of erugliflozin on liver fat, liver fibrosis, and glycemic control in patients with type 2 d…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease [NA]
This ClinicalTrials.gov entry describes a study aimed at optimizing noninvasive assessment of dysmetabolic compensated advanced liver diseas…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial of ZSP1601 in adults with Nonalcoholic Steatohepatitis (NASH); the study is cur…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
This clinical trial update notes ongoing recruitment for a study evaluating quantitative ultrasound methods to diagnose nonalcoholic steatoh…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
This clinical trial update describes a study on digital prevention strategies for nonalcoholic fatty liver disease and nonalcoholic steatohe…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
This completed clinical trial evaluated the MAFLD fibrosis score's ability to detect fibrotic NASH in Egyptian patients with metabolic-assoc…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH [Phase 2]
A Phase 2 trial is evaluating ASC41 tablets for safety, tolerability, and efficacy in adults with nonalcoholic fatty liver disease and nonal…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: The Liver Health Study for Patients with NAFLD [NA]
Clinical trial record describing the Liver Health Study for patients with nonalcoholic fatty liver disease, including nonalcoholic steatohep…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance [NA]
Stanford University is conducting a longitudinal multi-omic study to uncover mechanisms of obesity-mediated insulin resistance, with recruit…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver Disease [NA]
Clinical trial entry describing a study on the effects of phytosterol supplementation on liver function and inflammatory status in patients …
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)
A clinical trial protocol evaluating integrated phenotyping of the gut-platelet-liver axis to understand progression of chronic liver diseas…